These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 39107421

  • 1. Annual trends in atypical haemolytic uremic syndrome management in Japan and factors influencing early diagnosis and treatment: a retrospective study.
    Tatematsu Y, Imaizumi T, Michihata N, Kato N, Kumazawa R, Matsui H, Fushimi K, Yasunaga H, Maruyama S.
    Sci Rep; 2024 Aug 06; 14(1):18265. PubMed ID: 39107421
    [Abstract] [Full Text] [Related]

  • 2. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
    Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa L, Espinosa M, Grinyó JM, Macía M, Mendizábal S, Praga M, Román E, Torra R, Valdés F, Vilalta R, Rodríguez de Córdoba S.
    Nefrologia; 2015 Aug 06; 35(5):421-47. PubMed ID: 26456110
    [Abstract] [Full Text] [Related]

  • 3. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
    Krishnappa V, Gupta M, Elrifai M, Moftakhar B, Ensley MJ, Vachharajani TJ, Sethi SK, Raina R.
    Ther Apher Dial; 2018 Apr 06; 22(2):178-188. PubMed ID: 29250893
    [Abstract] [Full Text] [Related]

  • 4. Economic Impact of Early-in-Hospital Diagnosis and Initiation of Eculizumab in Atypical Haemolytic Uraemic Syndrome.
    Ryan M, Donato BMK, Irish W, Gasteyger C, L'Italien G, Laurence J.
    Pharmacoeconomics; 2020 Mar 06; 38(3):307-313. PubMed ID: 31828738
    [Abstract] [Full Text] [Related]

  • 5. Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Ito S, Hidaka Y, Inoue N, Kaname S, Kato H, Matsumoto M, Miyakawa Y, Mizuno M, Okada H, Shimono A, Matsuda T, Maruyama S, Fujimura Y, Nangaku M, Kagami S.
    Clin Exp Nephrol; 2019 Jan 06; 23(1):112-121. PubMed ID: 30039480
    [Abstract] [Full Text] [Related]

  • 6. Pregnancy-Associated Atypical Hemolytic Uremic Syndrome: A Systematic Review.
    Gupta M, Govindappagari S, Burwick RM.
    Obstet Gynecol; 2020 Jan 06; 135(1):46-58. PubMed ID: 31809447
    [Abstract] [Full Text] [Related]

  • 7. Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome.
    Greenbaum LA, Fila M, Ardissino G, Al-Akash SI, Evans J, Henning P, Lieberman KV, Maringhini S, Pape L, Rees L, van de Kar NC, Vande Walle J, Ogawa M, Bedrosian CL, Licht C.
    Kidney Int; 2016 Mar 06; 89(3):701-11. PubMed ID: 26880462
    [Abstract] [Full Text] [Related]

  • 8. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC, Cohney SJ, Kausman JY, Shortt J, Hughes PD, Wood EM, Isbel NM, de Malmanche T, Durkan A, Hissaria P, Blombery P, Barbour TD.
    Nephrology (Carlton); 2018 Jun 06; 23(6):507-517. PubMed ID: 29419916
    [Abstract] [Full Text] [Related]

  • 9. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC, Cohney SJ, Kausman JY, Shortt J, Hughes PD, Wood EM, Isbel NM, de Malmanche T, Durkan A, Hissaria P, Blombery P, Barbour TD.
    Intern Med J; 2018 Jun 06; 48(6):624-636. PubMed ID: 29582550
    [Abstract] [Full Text] [Related]

  • 10. Safety and effectiveness of eculizumab for adult patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Kato H, Miyakawa Y, Hidaka Y, Inoue N, Ito S, Kagami S, Kaname S, Matsumoto M, Mizuno M, Matsuda T, Shimono A, Maruyama S, Fujimura Y, Nangaku M, Okada H.
    Clin Exp Nephrol; 2019 Jan 06; 23(1):65-75. PubMed ID: 29959568
    [Abstract] [Full Text] [Related]

  • 11. Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.
    Fakhouri F, Hourmant M, Campistol JM, Cataland SR, Espinosa M, Gaber AO, Menne J, Minetti EE, Provôt F, Rondeau E, Ruggenenti P, Weekers LE, Ogawa M, Bedrosian CL, Legendre CM.
    Am J Kidney Dis; 2016 Jul 06; 68(1):84-93. PubMed ID: 27012908
    [Abstract] [Full Text] [Related]

  • 12. Indications of underdiagnosis of atypical haemolytic uraemic syndrome in a cohort referred to the Coagulation Unit in Malmo, Sweden, for analysis of ADAMTS13 2007-2012.
    Åkesson A, Blom AM, Klintman J, Zetterberg E.
    Nephrology (Carlton); 2017 Jul 06; 22(7):555-561. PubMed ID: 27175932
    [Abstract] [Full Text] [Related]

  • 13. A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome.
    Huerta A, Arjona E, Portoles J, Lopez-Sanchez P, Rabasco C, Espinosa M, Cavero T, Blasco M, Cao M, Manrique J, Cabello-Chavez V, Suñer M, Heras M, Fulladosa X, Belmar L, Sempere A, Peralta C, Castillo L, Arnau A, Praga M, Rodriguez de Cordoba S.
    Kidney Int; 2018 Feb 06; 93(2):450-459. PubMed ID: 28911789
    [Abstract] [Full Text] [Related]

  • 14. Eculizumab therapy on a patient with co-existent lupus nephritis and C3 mutation-related atypical haemolytic uremic syndrome: a case report.
    Kim MJ, Lee H, Kim YH, Jin SY, Kim HJ, Oh D, Jeon JS.
    BMC Nephrol; 2021 Mar 10; 22(1):86. PubMed ID: 33691638
    [Abstract] [Full Text] [Related]

  • 15. Clinical guides for atypical hemolytic uremic syndrome in Japan.
    Kato H, Nangaku M, Hataya H, Sawai T, Ashida A, Fujimaru R, Hidaka Y, Kaname S, Maruyama S, Yasuda T, Yoshida Y, Ito S, Hattori M, Miyakawa Y, Fujimura Y, Okada H, Kagami S, Joint Committee for the Revision of Clinical Guides of Atypical Hemolytic Uremic Syndrome in Japan.
    Pediatr Int; 2016 Jul 10; 58(7):549-55. PubMed ID: 27460397
    [Abstract] [Full Text] [Related]

  • 16. Renal recovery with eculizumab in atypical hemolytic uremic syndrome following prolonged dialysis.
    Povey H, Vundru R, Junglee N, Jibani M.
    Clin Nephrol; 2014 Nov 10; 82(5):326-31. PubMed ID: 23557793
    [Abstract] [Full Text] [Related]

  • 17. Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea.
    Cheong HI, Jo SK, Yoon SS, Cho H, Kim JS, Kim YO, Koo JR, Park Y, Park YS, Shin JI, Yoo KH, Oh D.
    J Korean Med Sci; 2016 Oct 10; 31(10):1516-28. PubMed ID: 27550478
    [Abstract] [Full Text] [Related]

  • 18. Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study.
    Menne J, Delmas Y, Fakhouri F, Licht C, Lommelé Å, Minetti EE, Provôt F, Rondeau E, Sheerin NS, Wang J, Weekers LE, Greenbaum LA.
    BMC Nephrol; 2019 Apr 10; 20(1):125. PubMed ID: 30971227
    [Abstract] [Full Text] [Related]

  • 19. Life-threatening pregnancy-associated atypical haemolytic uraemic syndrome and its response to eculizumab.
    Gately R, San A, Kurtkoti J, Parnham A.
    Nephrology (Carlton); 2017 Feb 10; 22 Suppl 1():32-35. PubMed ID: 28176475
    [Abstract] [Full Text] [Related]

  • 20. Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases.
    Fakhouri F, Delmas Y, Provot F, Barbet C, Karras A, Makdassi R, Courivaud C, Rifard K, Servais A, Allard C, Besson V, Cousin M, Châtelet V, Goujon JM, Coindre JP, Laurent G, Loirat C, Frémeaux-Bacchi V.
    Am J Kidney Dis; 2014 Jan 10; 63(1):40-8. PubMed ID: 24021908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.